Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
Plus components not separately reported this period.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
FAQ
- What is Arcutis Biotherapeutics, Inc.'s EBIT?
- Arcutis Biotherapeutics, Inc. (ARQT) reported EBIT of $16.43M in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s EBIT changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s EBIT increased by 212.4% year-over-year, from -$14.61M to $16.43M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s EBIT?
- Over 3 years (2021 to 2024), Arcutis Biotherapeutics, Inc.'s EBIT has grown at a -14.7% compound annual growth rate (CAGR), from -$206.53M to -$128.4M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Arcutis Biotherapeutics, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude